See the answer from Raúl Diaz, who directs MSD Animal Health Large Molecules Biopharm Operations in Montes Claros, Brazil.
See the answer from Chhaya Shah, SVP of tech ops at Radius Health.
See the answer from Leslie Williams, the former president, CEO, and founder of ImmusanT.
See the answer from Sandy Macrae, CEO of Sangamo Therapeutics.
See the answer from Tomasz Sablinski, M.D., Ph.D., the cofounder and board member of Transparency Life Sciences.
See the answer from Jeff Berkowitz, who serves on several biopharmaceutical company boards, including H. Lundbeck A/S.
See the answer from Anu Hans, VP of strategic initiatives, Janssen supply chain.
See the answer from John LaMattina, Ph.D., a senior partner at PureTech Health and the former senior VP at Pfizer and president of Pfizer Global Research and Development.
See the answer from Margaret Anderson, a managing director at Deloitte. She was previously executive director at FasterCures.
See the answer from Liz Bywater, Ph.D., speaker and author of Slow Down to Speed Up! She advises executives at some of the world’s most successful companies to drive growth, propel innovation, and lead change.
Get the latest articles from Life Science Leader delivered to your inbox.